Cardiopulmonary Exercise Testing Market Research Report–Global Forecast to 2023

$4,450$6,250

Cardiopulmonary Exercise Testing Market Research Report by Product (Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors, and Others), End-user (Hospital/Clinical Laboratories, Diagnostic Centers, Ambulatory Centers, and Others), and Region (APAC, Europe, North America, RoW)–Global Forecast to 2023

Clear

Description

Market analysis
Cardiopulmonary exercise testing is a viable method for diagnosing the heart condition and other cardiopulmonary traits. The test method incorporates checking the blood pressure, conducting the electrocardiography examination, and so on. Such tests are commonly practiced in developing nations attributable to the increasing health awareness among the individuals. This describes the exponential development of cardiopulmonary exercise testing in global regions like North America. The increasing prevalence of various cardiovascular diseases has led to an enhancement in the cardiopulmonary exercise testing in different global regions. The availability of the top-notch healthcare system has made the cardiopulmonary exercise testing highly competent in the global market. The global cardiopulmonary exercise testing market is projected to reach the valuation of USD 2248.21 Mn by growing at a CAGR of 5.75% during the forecast period (2018- 2023).
Market segmentation
The global cardiopulmonary exercise testing market is segmented on the basis of its product, end-user and regional demand. Based on its product, the global market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Stress Blood Pressure Monitors, Pulse Oximeters, Echocardiogram, Others. On the basis of its end-users, the market is classified into ambulatory centers, hospitals and clinics, diagnostic centers and others.
Regional analysis
Geographically, the global cardiopulmonary exercise testing market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major players
COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, among others are some of the major players in the global cardiopulmonary exercise testing market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising geriatric population
4.2.2 Rising cardiovascular diseases
4.2.3 Research and development
4.3 Restraints
4.3.1 High cost
4.3.2 Regulatory affairs
4.4 Opportunity
4.4.1 Entering developing markets
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Price Analysis
5.3 Investment Opportunity Analysis
5.4 Value Chain Analysis
5.4.1 Supporting Activity
5.4.2 Inbound Logistics
5.4.3 Operations
5.4.4 Marketing and Sales
5.4.5 Outbound Logistics
5.4.6 Customer Services
6 Global Cardiopulmonary Exercise Testing Market, by Product
6.1 Introduction
6.2 Cardiopulmonary Exercise Testing (CPET) Systems
6.3 Single-Photon Emission Computed Tomography (SPECT)
6.4 Echocardiogram
6.5 Pulse Oximeters
6.6 Stress Blood Pressure Monitors
7 Global Cardiopulmonary Exercise Testing Market, by End-User
7.1 Introduction
7.2 Hospitals and Clinics
7.3 Diagnostic Centers
7.4 Ambulatory Centers
7.5 Others
8 Global Cardiopulmonary Exercise Testing Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 U.K.
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East and Africa
8.5.1 Middle East
8.5.2 Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profiles
10.1 Cardinal Health
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offering
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategy
10.2 COSMED srl
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offering
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategy
10.3 GE Healthcare
10.3.1 Company Overview
10.3.2 Financial Overview (Healthcare Segment)
10.3.3 Products Offering
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategy
10.4 Halma plc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offering
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategy
10.5 Hill-Rom Holdings, Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offering
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategy
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offering
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategy
10.7 MGC Diagnostics Corporation
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offering
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategy
10.8 NIHON KOHDEN CORPORATION
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offering
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategy
10.9 Schiller AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offering
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategy
10.1 Masimo Corporation
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products Offering
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategy
10.11 Vyaire Medical, Inc.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products Offering
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.11.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print
11.2 References

Additional information

Publisher

Geography Covered

Date Published

Pages

Format